Biomarker sampling of the airways in asthma

Current Opinion in Pulmonary Medicine

Volumn 20, Issue 1, 2014, Pages 46-52

  Alexis, Neil E ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

airways inflammation; biomarker; lower airways; nasal airways

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; NITRIC OXIDE; STEROID; TUMOR NECROSIS FACTOR;

ACOUSTIC RHINOMETRY; ASTHMA; BREATHING; BRONCHOSCOPY; BRONCHUS BIOPSY; CYTOKINE RELEASE; ELECTRONIC NOSE; EOSINOPHIL; GENOMICS; HUMAN; HYDRATION; LOWER RESPIRATORY TRACT; NASAL BIOPSY; NASAL LAVAGE; NONHUMAN; PHENOTYPE; REVIEW; SAMPLING; SPUTUM; SPUTUM ANALYSIS; STANDARDIZATION;

ASTHMA; BIOLOGICAL MARKERS; BIOPSY; BREATH TESTS; BRONCHOSCOPY; HUMANS; NASAL LAVAGE; RESPIRATORY SYSTEM; RHINOMETRY, ACOUSTIC; SPUTUM;

EID: 84890027247     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0000000000000010     Document Type: Review

References (47)

1. Szefler SJ, Wenzel S, Brown R, et al. Asthma outcomes: Biomarkers. J Allergy Clin Immunol 2012; 129 (3 Suppl):S9-S23
2. Simpson JL, Scott R, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: Assessment and identification using induced sputum. Respirology 2006; 11:54-61
3. Vijverberg SJ, Hilvering B, Raaijmakers JA, et al. Clinical utility of asthma biomarkers: From bench to bedside. Biologics 2013; 7:199-210
4. Graham DE, Koren HS. Biomarkers of inflammation in ozone-exposed humans. Comparison of the nasal and bronchoalveolar lavage. Am Rev Respir Dis 1990; 142:152-156
5. Serrano CD, Valero A, Bartra J, et al. Nasal and bronchial inflammation after nasal allergen challenge: Assessment using noninvasive methods. J Investig Allergol Clin Immunol 2012; 22:351-356
6. Lemanske RF Jr, Dick EC, Swenson CA, et al. Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest 1989; 83:1-10
7. Di Lorenzo G, Pacor ML, Pellitteri ME, et al. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-Therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis. Clin Exp Allergy 2004; 34:259-266
8. Noah TL, Henderson FW, Henry MM, et al. Nasal lavage cytokines in normal, allergic, and asthmatic school-Age children. Am J Respir Crit Care Med 1995; 152 (4 Pt 1):1290-1296
9. Alexis N, Griffith K, Almond M, Peden DB. IL-4 induces IL-6 and signs of allergic-Type inflammation in the nasal airways of nonallergic individuals. Clin Immunol 2002; 104:217-220
10. Eldridge MW, Peden DB. Allergen provocation augments endotoxin-induced nasal inflammation in subjects with atopic asthma. J Allergy Clin Immunol 2000; 105:475-481
11. Peden DB, Setzer RW Jr, Devlin RB. Ozone exposure has both a priming effect on allergen-induced responses and an intrinsic inflammatory action in the nasal airways of perennially allergic asthmatics. Am J Respir Crit Care Med 1995; 151:1336-1345
12. Grünberg K, Timmers MC, Smits HH, et al. Effect of experimental rhinovirus 16 colds on airway hyperresponsiveness to histamine and interleukin-8 in nasal lavage in asthmatic subjects in vivo. Clin Exp Allergy 1997; 27:36-45
13. Greiff L, Pipkorn U, Alkner U, Persson CG. The 'nasal pool' device applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretions. Clin Exp Allergy 1990; 20:253-259
14. Kelly FJ, Mudway I, Blomberg A, et al. Altered lung antioxidant status in patients with mild asthma. Lancet 1999; 354:482-483
15. Kesic MJ, Hernandez M, Jaspers I. Airway protease/antiprotease imbalance in atopic asthmatics contributes to increased influenza A virus cleavage and replication. Respir Res 2012; 13:82
16. Choi GS, Kim JH, Shin YS, et al. Eosinophil activation and novel mediators in the aspirin-induced nasal response in AERD. Clin Exp Allergy 2013; 43:730-740
17. Noah TL, Zhou H, Zhang H, et al. Diesel exhaust exposure and nasal response to attenuated influenza in normal and allergic volunteers. Am J Respir Crit Care Med 2012; 185:179-185
18. Noah TL, Zhou H, Monaco J, et al. Tobacco smoke exposure and altered nasal responses to live attenuated influenza virus. Environ Health Perspect 2011; 119:78-83
19. Horvath KM, Herbst M, Zhou H, et al. Nasal lavage natural killer cell function is suppressed in smokers after live attenuated influenza virus. Respir Res 2011; 12:102
20. Acouetey DS, Zmirou-Navier D, Avogbe P, et al. Genetic predictors of inflammation in the risk of occupational asthma in young apprentices. Ann Allergy Asthma Immunol 2013; 110:423-428
21. Horvath KM, Brighton LE, Herbst M, et al. Live attenuated influenza virus (LAIV) induces different mucosal T cell function in nonsmokers and smokers. Clin Immunol 2012; 142:232-236
22. Williamson PA, Vaidyanathan S, Clearie K, et al. Relationship between fractional exhaled nitric oxide and nasal nitric oxide in airways disease. Ann Allergy Asthma Immunol 2010; 105:162-167
23. Valero A, Serrano C, Valera JL, et al. Nasal and bronchial response to exercise in patients with asthma and rhinitis: The role of nitric oxide. Allergy 2005; 60:1126-1131
24. Fisher EW, Lund VJ, Scadding GK. Acoustic rhinometry in rhinological practice: Discussion paper. J R Soc Med 1994; 87:411-413
25. Alexis NE, Hu SC, Zeman K, et al. Induced sputum derives from the central airways: Confirmation using a radiolabeled aerosol bolus delivery technique. Am J Respir Crit Care Med 2001; 164 (10 Pt 1):1964-1970
26. Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: A randomized controlled trial. Lancet 2002; 360:1715-1721
27. Koh GC, Shek LP, Goh DY, et al. Eosinophil cationic protein: Is it useful in asthmä A systematic review. Respir Med 2007; 101:696-705
28. Kim CK, Callaway Z, Fletcher R, Koh YY. Eosinophil-Derived neurotoxin in childhood asthma: Correlation with disease severity. J Asthma 2010; 47:568-573
29. Brickey WJ, Alexis NE, Hernandez ML, et al. Sputum inflammatory cells from patients with allergic rhinitis and asthma have decreased inflammasome gene expression. J Allergy Clin Immunol 2011; 128:900-903
30. Alexis NE, Brickey WJ, Lay JC, et al. Development of an inhaled endotoxin challenge protocol for characterizing evoked cell surface phenotype and genomic responses of airway cells in allergic individuals. Ann Allergy Asthma Immunol 2008; 100:206-215
31. Alexis NE, Soukup J, Nierkens S, Becker S. Association between airway hyperreactivity and bronchial macrophage dysfunction in individuals with mild asthma. Am J Physiol Lung Cell Mol Physiol 2001; 280:L369-L375
32. Loughlin CE, Esther CR Jr, Lazarowski ER, et al. Neutrophilic inflammation is associated with altered airway hydration in stable asthmatics. Respir Med 2010; 104:29-33
33. Brightling CE, Symon FA, Birring SS, et al. TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis. J Allergy Clin Immunol 2002; 110:899-905
34. Alexis N, Soukup J, Ghio A, Becker S. Sputum phagocytes from healthy individuals are functional and activated: A flow cytometric comparison with cells in bronchoalveolar lavage and peripheral blood. Clin Immunol 2000; 97:21-32
35. Goleva E, Jackson LP, Harris JK, et al. The effects of airway microbiome on corticosteroid responsiveness in asthma. Am J Respir Crit Care Med 2013. [Epub ahead of print
36. Esnault S, Kelly EA, Schwantes EA, et al. Identification of genes expressed by human airway eosinophils after an in vivo allergen challenge. PLoS One 2013; 8:e67560
37. Kharitonov SA, Yates D, Robbins RA, et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343:133-135
38. Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993; 6:1368-1370
39. Pijnenburg MW, De Jongste JC. Exhaled nitric oxide in childhood asthma: A review. Clin Exp Allergy 2008; 38:246-259
40. Petsky HL, Cates CJ, Li AM, et al. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults. Cochrane Database Syst Rev 2008; 2:CD006340
41. Zacharasiewicz A, Wilson N, Lex C, et al. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med 2005; 171:1077-1082
42. Dragonieri S, Schot R, Mertens BJ, et al. An electronic nose in the discrimination of patients with asthma and controls. J Allergy Clin Immunol 2007; 120:856-862
43. Fens N, Zwinderman AH, Van Der Schee MP, et al. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med 2009; 180:1076-1082
44. Esther CR Jr, Boysen G, Olsen BM, et al. Mass spectrometric analysis of biomarkers and dilution markers in exhaled breath condensate reveals elevated purines in asthma and cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 2009; 296:L987-L993
45. Loukides S, Bouros D, Papatheodorou G, et al. H(2)O(2) in steadystate bronchiectasis: Relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease. Chest 2002; 121: 81-87
46. Montuschi P, Barnes PJ, Ciabattoni G. Measurement of 8-isoprostane in exhaled breath condensate. Methods Mol Biol 2010; 594:73-84
47. Tseliou E, Bessa V, Hillas G, et al. Exhaled nitric oxide and exhaled breath condensate pH in severe refractory asthma. Chest 2010; 138: 107-113